Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-09-009944
Filing Date
2009-06-19
Accepted
2009-06-19 17:26:25
Documents
2
Period of Report
2009-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3844
2 ex24pearce.txt EX-24 3154
  Complete submission text file 0001179110-09-009944.txt   8883
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 84 CLIFDEN ZIONSVILLE IN 46077
Business Address
Pearce Homer L (Reporting) CIK: 0001368009 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 09902095